International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson’s Disease Clinical Trial

International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson’s Disease Clinical Trial
CARLSBAD, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQX: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage ... read more
Source: Bing NewsPublished on 2019-04-29